Patent · US Active

Rifaximin

US8633234B2 · kind B2 · utility

9Cited by

5References

1Claims

0Family size

Assignee

Cipla Limited · IN

Inventors

Dharmaraj Ramachandra Rao · Jamkhed, IN
Rajendra Narayanrao Kankan · Jamkhed, IN
Manjinder Singh Phull · Mumbai, IN
Maruti Ghagare · Jamkhed, IN

Key dates

Filing date	Sep 24, 2007
Grant date	Jan 21, 2014
Priority date	—
Expiry date	Nov 2, 2029

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Amorphous rifaximin, methods of making it, and pharmaceutical compositions containing it. Also described are methods of converting amorphous rifaximin to crystalline rifaximin and vice versa.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.